Loading...

Nephros, Inc.

NEPH•NASDAQ
Healthcare
Medical - Instruments & Supplies
$4.19
$0.01(0.24%)

Nephros, Inc. (NEPH) Stock Overview

Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.4/100

Key Financials

Market Cap44.4M
P/E Ratio33.55
EPS (TTM)$0.12
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Week$3.61
1 Month$3.32
3 Months$1.15
1 Year Target$0.63

NEPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nephros, Inc. (NEPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.55 and a market capitalization of 44.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.60%
5-Day Change
-9.95%
1-Month Change
17.28%
3-Month Change
25.83%
6-Month Change
30.14%
Year-to-Date (YTD) Change
30.14%
1-Year Change
-10.38%
3-Year Change
-58.96%
5-Year Change
-75.80%
All-Time (Max) Change
-99.82%

Contact Information

https://www.nephros.com
201 343 5202
380 Lackawanna Place, South Orange, NJ, 07079

Company Facts

31 Employees
IPO DateSep 21, 2004
CountryUS
Actively Trading

Frequently Asked Questions

;